190 related articles for article (PubMed ID: 9691524)
1. [Prognostic factors of cancer of the endometrium and therapeutic implications].
Michel G; Morice P; Castaigne D; Lanoux P; Pautier P; Lhommé C; Gerbaulet A; Duvillard P
Contracept Fertil Sex; 1998 Jun; 26(6):452-6. PubMed ID: 9691524
[TBL] [Abstract][Full Text] [Related]
2. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
[TBL] [Abstract][Full Text] [Related]
3. Steroid hormone receptor content and lymph node status in endometrial cancer.
Morris PC; Anderson JR; Anderson B; Buller RE
Gynecol Oncol; 1995 Mar; 56(3):406-11. PubMed ID: 7705676
[TBL] [Abstract][Full Text] [Related]
4. Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology.
Lutman CV; Havrilesky LJ; Cragun JM; Secord AA; Calingaert B; Berchuck A; Clarke-Pearson DL; Soper JT
Gynecol Oncol; 2006 Jul; 102(1):92-7. PubMed ID: 16406063
[TBL] [Abstract][Full Text] [Related]
5. Stage IB endometrial cancer. Does lymphadenectomy replace adjuvant radiotherapy?
Bottke D; Wiegel T; Kreienberg R; Kurzeder C; Sauer G
Strahlenther Onkol; 2007 Nov; 183(11):600-4. PubMed ID: 17960334
[TBL] [Abstract][Full Text] [Related]
6. The long-term survival of women with surgical stage II endometrioid type endometrial cancer.
Ayhan A; Taskiran C; Celik C; Yuce K
Gynecol Oncol; 2004 Apr; 93(1):9-13. PubMed ID: 15047207
[TBL] [Abstract][Full Text] [Related]
7. [Pelvic lymphadenectomy as an alternative to adjuvant radiotherapy in early stage endometrial cancer at high risk of recurrent lymphatic metastases (stage I)].
Amato NA; Partipilo V; Mele F; Boscia F; De Marzo P
Minerva Ginecol; 2009 Feb; 61(1):1-12. PubMed ID: 19204656
[TBL] [Abstract][Full Text] [Related]
8. Routine pelvic lymphadenectomy in apparently early stage endometrial cancer.
Zuurendonk LD; Smit RA; Mol BW; Feijen HW; de Graaff J; Sykora D; de Winter KA; vd Wurff A; Snijders MP; Kruitwagen RF
Eur J Surg Oncol; 2006 May; 32(4):450-4. PubMed ID: 16546343
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of progesterone receptor immunohistochemistry for lymph node metastases in endometrial carcinoma.
Iwai K; Fukuda K; Hachisuga T; Mori M; Uchiyama M; Iwasaka T; Sugimori H
Gynecol Oncol; 1999 Mar; 72(3):351-9. PubMed ID: 10053107
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcomes of therapeutic pelvic lymphadenectomy for stage I endometrial adenocarcinoma.
Mohan DS; Samuels MA; Selim MA; Shalodi AD; Ellis RJ; Samuels JR; Yun HJ
Gynecol Oncol; 1998 Aug; 70(2):165-71. PubMed ID: 9740684
[TBL] [Abstract][Full Text] [Related]
11. Surgical staging for patients presenting with grade 1 endometrial carcinoma.
Ben-Shachar I; Pavelka J; Cohn DE; Copeland LJ; Ramirez N; Manolitsas T; Fowler JM
Obstet Gynecol; 2005 Mar; 105(3):487-93. PubMed ID: 15738013
[TBL] [Abstract][Full Text] [Related]
12. Preoperative cervical cytology in endometrial carcinoma and its clinicopathologic relevance.
Fukuda K; Mori M; Uchiyama M; Iwai K; Iwasaka T; Sugimori H; Yamasaki F
Gynecol Oncol; 1999 Mar; 72(3):273-7. PubMed ID: 10053095
[TBL] [Abstract][Full Text] [Related]
13. [Effect of pelvic lymphadenectomy on prognosis of endometrial carcinoma].
Wen HW; Zhang LD
Zhonghua Fu Chan Ke Za Zhi; 2004 Mar; 39(3):152-5. PubMed ID: 15130370
[TBL] [Abstract][Full Text] [Related]
14. [Multivariate analysis of prognostic factors in endometrial carcinoma].
Li B; Wu LY; Li SM; Zhang WH; Zhang R; Ma SK
Ai Zheng; 2004 Sep; 23(9):1085-8. PubMed ID: 15363208
[TBL] [Abstract][Full Text] [Related]
15. Para-aortic lymphadenectomy may improve disease-related survival in patients with multipositive pelvic lymph node stage IIIc endometrial cancer.
Fujimoto T; Nanjyo H; Nakamura A; Yokoyama Y; Takano T; Shoji T; Nakahara K; Yamada H; Mizunuma H; Yaegashi N; Sugiyama T; Kurachi H; Sato A; Tanaka T
Gynecol Oncol; 2007 Nov; 107(2):253-9. PubMed ID: 17640720
[TBL] [Abstract][Full Text] [Related]
16. [Endometrial adenocarcinoma treated with combined radiotherapy and surgery: 437 cases].
Touboul E; Belkacémi Y; Buffat L; Deniaud-Alexandre E; Lefranc JP; Lhuillier P; Uzan S; Jannet D; Uzan M; Antoine M; Ginesty C; Ganansia V; Jamali M; Milliez J; Blondon J; Schlienger M
Cancer Radiother; 2001 Aug; 5(4):425-44. PubMed ID: 11521391
[TBL] [Abstract][Full Text] [Related]
17. [Risk factors and prognosis of node-positive cervical carcinoma].
Feng SY; Zhang YN; Liu JG
Ai Zheng; 2005 Oct; 24(10):1261-6. PubMed ID: 16219145
[TBL] [Abstract][Full Text] [Related]
18. FIGO stage IIIC endometrial carcinoma with metastases confined to pelvic lymph nodes: analysis of treatment outcomes, prognostic variables, and failure patterns following adjuvant radiation therapy.
Nelson G; Randall M; Sutton G; Moore D; Hurteau J; Look K
Gynecol Oncol; 1999 Nov; 75(2):211-4. PubMed ID: 10525373
[TBL] [Abstract][Full Text] [Related]
19. 5-year survival rate in endometrial carcinoma stage I-II related to steroid receptor concentration, degree of differentiation, age and myometrial invasion.
Lindahl B; Fernö M; Gullberg B; Norgren A; Willén R
Anticancer Res; 1992; 12(2):409-12. PubMed ID: 1580559
[TBL] [Abstract][Full Text] [Related]
20. Pelvic lymphadenectomy as alternative to postoperative radiotherapy in high risk early stage endometrial cancer.
Papanikolaou A; Kalogiannidis I; Goutzioulis M; Misailidou D; Makedos A; Vergote I; Makedos G
Arch Gynecol Obstet; 2006 May; 274(2):91-6. PubMed ID: 16518607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]